Home- Request Live
Reimbursement Support - Request a Rep
WELLBUTRIN XL
When Experience Matters
Rely on 20 years and counting of clinical experience in treating MDD/SAD1,2 and the WELLBUTRIN XL Savings & Access Program to help.
MDD, major depressive disorder; SAD, seasonal affective disorder.
WELLBUTRIN XL Savings & Access Program
We are here to help patients access and afford WELLBUTRIN XL. The WELLBUTRIN XL Savings & Access Program consists of:
Prior authorization (PA) supportPA CONSIDERATIONS >> Request Live Reimbursement Support >>
Resources to help healthcare professional teams manage the PA process
PA CONSIDERATIONS FOR WELLBUTRIN XL >>
Copay savingsENROLLMENT >>CARD ACTIVATION >>
Most eligible* commercially insured patients may pay as low as $5 for a 30-day supply
*This offer is not valid for patients covered by Medicare, Medicaid or any other federal or state funded healthcare program or where prohibited by law. Please see full eligibility criteria above.
Free delivery of WELLBUTRIN XL DOWNLOAD FORM >>
PhilRx program highlights
- Deliver medications directly to the patient through an independent pharmacy network
- Apply a monthly copay as low as $5 for eligible* commercially insured patients
- Schedule refills
- Troubleshoot insurance
Get started with PhilRx
1. Healthcare professionals should send a patient’s WELLBUTRIN XL prescription to PhilRx
2. PhilRx will process it and text the patient for insurance and delivery information
*This offer is not valid for patients covered by Medicare, Medicaid or any other federal or state funded healthcare program or where prohibited by law. Please see full eligibility criteria above.
Assistance with insurance coverage REGISTER NOW >>
WELLBUTRIN XL support from CoverMyMeds® allows healthcare professionals to:
- Manage quick and efficient prior authorizations
- Receive fast approvals
- Automatically renew previous prior authorizations
Reasons to Prescribe a Brand Name Experience
The generic versions of WELLBUTRIN XL may look considerably different from the original branded product
Graphic representation of WELLBUTRIN XL and generic versions of WELLBUTRIN XL. Not actual size.
- Changes in sizes, shapes, colors, tastes, smells, and packaging of generic medications compared with branded drug can potentially impact treatment adherence3,4
- Patients and healthcare professionals can find it difficult to correctly identify medications, which can lead to errors3,4
- In a study in patients with MDD, researchers found that treatment adherence and persistence were higher in patients treated with 3 branded antidepressants (serotonin reuptake inhibitors) vs those receiving the generic alternatives5,6
Write/Select DAW1, Brand Medically Necessary on your WELLBUTRIN XL scripts
to help ensure patients get the brand name product and potentially avoid adherence issues.3,4
*Disclaimer: This code is for informational purposes only. It represents no statement, promise, or guarantee by Bausch Health Companies Inc. concerning coverage and/or levels of reimbursement, payment, or charge and is not intended to increase or maximize reimbursement by any payer. It is the responsibility of the healthcare provider to determine the appropriate code(s) for service provided to his or her patient.
Free Samples
Get your patients started on WELLBUTRIN XL in the office with free samples.
References:
- WELLBUTRIN XL (bupropion hydrochloride extended-release) Prescribing Information. Bausch Health Companies Inc.
- Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21515ltr.pdf. Accessed May 10, 2023.
- Straka RJ, Keohane DJ, Liu LZ. Potential clinical and economic impact of switching branded medications to generics. Am J Ther. 2017;24(3):e278-e289.
- Peters JR. From our perspective: the importance of the physical characteristics of generic drugs. U.S. Food & Drug Administration. https://www.fda.gov/drugs/newsevents/ucm471446.htm. Accessed May 10, 2023.
- Italiano D, Spina E. Generic antidepressant drugs: a reappraisal. J Psychopathology. 2013;19(3):I-V.
- Liu X, Chen Y, Faries DE. Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder. Clinicoecon Outcomes Res. 2011;3:63-72.
INDICATION
WELLBUTRIN XL® (bupropion hydrochloride extended-release tablets) is indicated for the treatment of major depressive disorder (MDD), and for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient.
IMPORTANT SAFETY INFORMATION
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
SUICIDALITY AND ANTIDEPRESSANT DRUGS:
Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. These trials did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in subjects aged 65 and older.
In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.